CTCFL Produits
(CCCTC-Binding Factor (Zinc Finger Protein)-Like (CTCFL))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories CTCFL en vedette
CTCFL Anticorps
High quality antibodies with extensive validation data.
CTCFL Kits ELISA
Reliable ELISA kits for a wide range of species.
CTCFL Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
CTCFL recommandé Anticorps
- (2)
- (6)
- (1)
- (2)
CTCFL recommandé Kits ELISA
- (1)
CTCFL recommandé Protéines
- (1)
- (1)
Dernières publications sur nos produits CTCFL
: "BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells." dans: Cell death discovery, Vol. 6, pp. 1, (2020) (PubMed).: "Expression of cancer/testis antigens is correlated with improved survival in glioblastoma." dans: Oncotarget, Vol. 4, Issue 4, pp. 636-46, (2013) (PubMed).
: "A cell cycle role for the epigenetic factor CTCF-L/BORIS." dans: PLoS ONE, Vol. 7, Issue 6, pp. e39371, (2012) (PubMed).
: "Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma." dans: Cell cycle (Georgetown, Tex.), Vol. 11, Issue 9, pp. 1841-50, (2012) (PubMed).
: "CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer." dans: Molecular cancer research : MCR, Vol. 9, Issue 2, pp. 225-33, (2011) (PubMed).
: "Widespread expression of BORIS/CTCFL in normal and cancer cells." dans: PLoS ONE, Vol. 6, Issue 7, pp. e22399, (2011) (PubMed).
: "BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 13, pp. 4267-76, (2011) (PubMed).
: "BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas." dans: PLoS ONE, Vol. 5, Issue 3, pp. e9738, (2010) (PubMed).
: "Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development." dans: Molecular human reproduction, Vol. 14, Issue 6, pp. 347-55, (2008) (PubMed).
: "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS." dans: Biochemical and biophysical research communications, Vol. 370, Issue 1, pp. 109-12, (2008) (PubMed).
Synonymes et noms alternatifs relatifs à CTCFL
CCCTC-binding factor like (CTCFL), CCCTC-binding factor (zinc finger protein)-like (Ctcfl), CCCTC-binding factor like (Ctcfl), BORIS, Boris, CT27, CTCF-T, CTCFL, dJ579F20.2, HMGB1L1, OTTMUSG00000016680Protein level used designations for CTCFL
- BORIS-like protein
- CTCF paralog
- CTCF-like protein
- HMG-1L1
- brother of the regulator of imprinted sites
- cancer/testis antigen 27
- putative high mobility group protein 1-like 1
- putative high mobility group protein B1-like 1
- transcriptional repressor CTCFL
- zinc finger protein CTCF-T
- CCCTC-binding factor (zinc finger protein)-like
- CCCTC-binding factor-like protein
- BORIS
- Brother of the regulator of imprinted sites
- likely orthologue of H. sapiens CCCTC-binding factor-like protein (CTCFL)
- brother of regulator of imprinted sites
- transcriptional repressor CTCFL-like
Avez-vous cherché autre chose?
- CTCF
- CTC1
- CTBS
- CTBP2
- CTBP1-AS1
- CTBP1
- CTAGE9
- CTAGE8
- CTAGE7P
- CTAGE6
- CTAGE4
- CTAGE3P
- CTAGE15
- CTAGE1
- CTAG2
- CTAG1B
- CTAG1A
- CT62
- CT47B1
- CT47A7
- CTD (Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide A) Small Phosphatase Like 2
- CTD Nuclear Envelope Phosphatase 1 Regulatory Subunit 1
- CTDNEP1A
- CTDNEP1B
- CTDP1
- CTDSP1
- CTDSP2
- CTDSPL
- CTF18
- CTGF
- CTGLF11P
- CTH
- CTHRC1
- CTIF/KIAA0427
- CTK3
- CTLA-4 (Ipilimumab Biosimilar)
- CTLA-4 (Tremelimumab Biosimilar)
- CTLA2A
- Ctla2b
- CTLA4